{"slug":"tesamorelin-muscle-loss","verification":{"valid":true,"entries":2,"head":"19fbfa92b36bdaf0eb9f55164dc454f801ea701aad9e0d7c424975e61ff55919"},"energy":{"passes":2,"tokens_in":28916,"tokens_out":3094,"tokens_total":32010,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"19fbfa92b36bdaf0eb9f55164dc454f801ea701aad9e0d7c424975e61ff55919"},"provenance":[{"ts":"2026-06-29T23:19:00.263Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tesamorelin for Muscle Loss\nSlug: tesamorelin-muscle-loss\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tesamorelin\",\"name\":\"Tesamorelin\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tesamorelin\",\"name\":\"Tesamorelin\",\"section_title\":\"Why Tesamorelin might help you\",\"layer\":\"GH axis / visceral fat\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Tesamorelin** → GH axis / visceral fat\",\"section_headings\":[\"What's breaking down\",\"Why Tesamorelin might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one pept","response":"{\n  \"slug\": \"tesamorelin-muscle-loss\",\n  \"title\": \"Tesamorelin for Muscle Loss: Human Evidence on Lean Mass, Muscle Density, and the GH Axis\",\n  \"body\": \"## What's breaking down\\nMuscle loss, or sarcopenia-like decline, often stems from reduced growth hormone (GH) signaling with age or illness. This lowers IGF-1, slowing protein synthesis while catabolic processes continue. Visceral fat accumulation adds mechanical and inflammatory stress that can further impair muscle quality. In HIV-related lipodystrophy, excess abdominal fat pairs with muscle fat infiltration and reduced lean area. Repair pathways lag behind breakdown when GH pulses weaken. Tesamorelin is discussed here because studies examine its effect on the GH axis and downstream tissue changes rather than symptom masking.\\n\\n## Why Tesamorelin might help you\\nIf your muscle loss involves low GH/IGF-1 activity or excess visceral fat, the logic chain runs like this. Tesamorelin stimulates the pituitary to release endogenous GH in a more physiologic pattern. That raises circulating IGF-1. Higher IGF-1 supports protein synthesis in muscle tissue. In people who respond with visceral fat reduction, CT scans showed measurable gains in trunk muscle density and lean muscle area over 26 weeks. Therefore, if visceral fat or poor muscle quality is part of your profile, the compound is studied for its potential to shift the balance toward tissue-level repair signals instead of only lowering fat mass.\\n\\nStep 1: GH release increases. Step 2: IGF-1 rises in a pulsatile way. Step 3: Muscle protein turnover favors synthesis. Step 4: In responders, muscle fat decreases and lean area increases on imaging. This targets the regenerative side of the equation for the layers listed above.\\n\\n## How these fit together\\nSingle-compound focus. Tesamorelin maps directly to the GH axis and visceral fat layer. If your situation includes multiple degeneration layers, this agent addresses the endocrine and body-composition component. Other","tokens_in":28916,"tokens_out":3094,"cost":0,"prev":"genesis","hash":"b893f8d91bcfbfd430c532f9f3d2c122415b4396cf0188fe404dfd7fcdea664f"},{"ts":"2026-07-17T02:42:24.087Z","model":"owner","action":"voxel_divide","prompt":"","input":"tesamorelin-muscle-loss","response":"19 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"b893f8d91bcfbfd430c532f9f3d2c122415b4396cf0188fe404dfd7fcdea664f","hash":"19fbfa92b36bdaf0eb9f55164dc454f801ea701aad9e0d7c424975e61ff55919"}]}